Neurocrine Biosciences | NBIX - القيمة السوقية

سعر السهم
133.06
التغيير اليومي
1.83 1.39%
شهريا
1.00%
سنويا
24.83%
Q2 التوقعات
124.95




القيمة السوقية تغيير تاريخ
AbbVie USD 360.74B 23.94B 2026-04
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.6B 410M 2026-04
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 40.54B 12B 2026-04
Amgen USD 187.49B 11.24B 2026-04
Biogen USD 28.34B 1.44B 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Halozyme Therapeutics USD 7.91B 664M 2025-12
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.9B 1.55B 2026-04
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Prothena USD 514M 11M 2025-12
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Repligen USD 9.22B 1.7B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 116.7B 82.42B 2026-04
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12